On August 23, some investors asked Chison Medical Technologies through the interactive platform: There are brokerage research reports claiming that the company signed a cooperation agreement with Royal Philips in May this year. Is it true? How much impact does this agreement have on the annual performance? Chison Medical Technologies responded: The company established a partnership with Royal Philips in the first half of 2023, and together they will collaborate in the field of mobile ultrasound to improve the efficiency and work experience of doctors' clinical diagnosis, and promote the high-quality development of precision diagnosis and treatment in China. At present, the cooperation between the two parties is progressing in an orderly manner, and the relevant content of the cooperation is commercial confidential information, which cannot be disclosed publicly.